Generic Zyrtec Recalled: Check Your Bottle Now

Most people grab their allergy pills without a second thought — especially a familiar name like Zyrtec. But right now, the FDA is urging millions of Americans to stop and check their bottle before taking another dose.

A nationwide recall has been issued for certain generic versions of cetirizine hydrochloride, the active ingredient in Zyrtec, after the pills were found potentially contaminated with an entirely different medication — one that could trigger a life-threatening reaction in some people.

What Triggered the Recall

The problem was caught the way many drug safety issues are: by chance. A pharmacy technician noticed something odd while counting cetirizine tablets — some had red dots, others appeared discolored. That observation set off a chain of testing that led Unique Pharmaceutical Laboratories to voluntarily recall four lots of its 5 mg cetirizine tablets on July 18, 2026.

The culprit? Ranitidine — a heartburn medication (formerly sold as Zantac) that ended up mixed in with the allergy tablets during the manufacturing process. For most people, this might be a minor issue. But for anyone with a hypersensitivity to ranitidine or its ingredients, ingesting even trace amounts can trigger anaphylaxis — a severe, potentially fatal allergic reaction.

Who Is at Risk

The FDA has classified this as a serious recall with the potential for severe adverse health consequences. Specific symptoms that could occur in sensitive individuals include:

• Sudden drop in blood pressure
• Difficulty breathing or swallowing
• Swelling of the throat or face
• Generalized hives and itching
• Loss of consciousness

As of the recall date, no adverse events have been reported. But the FDA stresses that for people with ranitidine hypersensitivity, the risk is real and immediate.

How to Check If Your Medication Is Affected

This recall applies only to specific lots distributed by Rising Pharma Holdings Inc. — not to brand-name Zyrtec or other manufacturers' cetirizine products. Here is exactly what to look for on your bottle:

• Product: Cetirizine Hydrochloride Tablets USP 5 mg
• NDC Number: 16571-401-10
• Package: 100-count HDPE bottle
• Expiration Date: October 2028
• Recalled Lot Numbers: GY825029 / GY825030 / GY825031 / GY825032

If your bottle matches any of those lot numbers, stop using it immediately. The medication was distributed nationwide to wholesalers and retailers across the United States.

What You Should Do Right Now

If you have an affected bottle, do not throw it away — return it to the pharmacy or retailer where you purchased it. Rising Pharma is arranging returns for all recalled products.

For questions about the recall, you can reach Rising Pharma Holdings directly:

• Phone: 1-844-874-7464 (Monday–Friday, 8 a.m. to 5 p.m. ET)
• Email: pv@risingpharma.com or qa@risingpharma.com

If you believe you've already taken contaminated tablets and are experiencing any symptoms — especially difficulty breathing or swelling — seek emergency medical care immediately and contact your physician.

To report side effects or adverse events directly to the FDA, use the MedWatch Adverse Event Reporting Program online or call 1-800-332-1088.

The Bigger Picture: Generic Drug Safety

This recall is a reminder that generic medications — while chemically equivalent to brand-name drugs — go through the same manufacturing risks as any mass-produced product. Cross-contamination events, while rare, do happen. The system worked here: a sharp-eyed technician caught the problem before any known injuries occurred.

Staying informed about recalls is one of the simplest things you can do to protect your household. Bookmark the FDA Drug Recalls page and check it periodically — especially if you take multiple over-the-counter or prescription medications regularly.